In order to further verify our screening results, we selected C6- quercetin, an important active compound in the treatment of cervical cancer by Hedyotis diffusa, for molecular docking with the core targets IL1B and IL6 which have prognostic value for cervical cancer respectively. This evidence concerns the gene IL1B and cervical carcinoma.